One cancer patient’s immunotherapy clinical trial, an approach with hopeful results, could have implications for others seeking treatment.

Learn about CAR T-cell therapy, a state-of-the-art FDA approved leukemia gene therapy, which the University of Michigan C.S. Mott Children's Hospital offers.

Learn when active surveillance of low risk thyroid, prostate and breast cancer, may be appropriate and whether this approach could reduce overtreatment.

As more biomarker-based studies open, such testing will increase opportunities to match patients with clinical trials.

Hospitals and health systems nationwide, including Michigan Medicine, now tap advocates who bring compassionate and customized help to cancer patients.

Despite having stage 4 prostate cancer, 74 year old Woods Brown remains active by fishing and planting. Learn more about Woods and living with prostate cancer.

The Oncology Care Model is a payment and practice reform initiative for cancer patients who use Medicare and receive chemotherapy. Learn more about the program.

Physiatrists use knowledge of the musculoskeletal system to treat patients for cancer symptom management and recovery. Read more about Physiatrists and cancer.

Immunotherapy is the use of the body’s own immune system to fight cancer. Learn more about the different types of immunotherapy and which cancers they fight.

Three University of Michigan cancer clinical trial participants share their experiences. Learn about the cancers they were fighting and how they are doing today.

Clinical studies push cancer research forward, creating new cancer therapies and refining existing ones. An R.N. encourages cancer patients to participate.

Doctors at C.S. Mott Children’s Hospital 3-D printed a replica of a fifth grader’s tumor — Boris — to show it’s possible to fight back against cancer.

Researchers at the University of Michigan report a new understanding of the enzyme P-Rex1 and how it binds to a signaling lipid called PIP3 in cancer metastasis.

Advances in medical technology allow the team at the University of Michigan Cancer Center to monitor patient's tumors in real-time during radiation therapy.